Biotech Values

[kei]

XXII $3.82 ~ tobacco related info: https://seekingalpha.com/news/3323678-22nd-century-group-builds-rally-11-percent

hit new 52wk high yesterday (it was 84 cents last January)

22nd Century Group builds on rally, up 11%
Jan. 18, 2018 3:50 PM ET|By: Douglas W. House, SA News Editor
Plant biotech outfit 22nd Century Group (XXII +11.4%) continues its up move on double normal volume. Shares have rallied 90% since early November.

Next week, the FDA's Tobacco Products Scientific Advisory Committee will meet to discuss the modified risk tobacco applications from Philip Morris (MO -0.1%) (Wednesday and Thursday, 1/24 & 1/25).

A Phase 3 clinical trial evaluating 22nd's SPECTRUM Very Low Nicotine (VLN) cigarettes is ongoing. The estimated completion date is March.